Author Archive

Clock Ticking for Psoriasis Drug Raptiva: On it? Get off!

May 29th, 2009. By admin

On Raptiva? Then the clock’s ticking. Your pharmacy will only give you a refill on your prescription till until Monday, June 8^th. While we’re happy that Genentech decided to voluntarily withdraw Raptiva from the market given the drug’s link to the deadly progressive multifocal leukoencephalopathy (PML) infection, there’s one thing Genentech couldn’t take away: patients’ stress.

Think about it-you’re on Raptiva for psoriasis and you’ve been told that stopping Raptiva at once could either worsen your psoriasis or, worse yet, necessitate hospitalization. That’ll give you pause if you’re considering going cold turkey. But then again, you did receive that letter in the mail from Genentech advising you that you’ll need to stop taking it. Feeling caught between a rock and a hard place? You should be.

But before you stress yourself out even more, see your doctor first. You and your doctor need to come up with a plan to switch to another psoriasis treatment before coming off Raptiva. Beyond that (as if that isn’t enough), if you any questions about what recourse you may have as a result of being on Raptiva and being told you need to come off it pronto, you may want to ask a lawyer about your situation.

Tags: Psoriasis drug, Raptiva, Raptiva PML Brain Infection
Posted in Drugs/Medical | No Comments »

California Labor sees Job Market Shift?

May 25th, 2009. By admin

Came across this one, had to share…wonder if anyone asked about overtime?

job_market_2009_311

Tags: California IT overtime, California labor law
Posted in Emerging Issues | No Comments »

Emcore Corporation EMKR Securities Stock Fraud

December 30th, 2008. By admin

Company:	Emcore Corporation
Ticker Symbol:	EMKR
Class Period:	Jun-12-07 to Mar-17-08
Date Filed:	Dec-24-08
Lead Plaintiff Deadline:	Feb-22-09
Court:	District of New Mexico
Allegations:

On December 24, 2008, a class action lawsuit was filed in the United States District Court for the District of New Mexico against Emcore Corporation (“Emcore” or the “Company”) (Nasdaq:EMKR). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations that Emcore issued a series of material misrepresentations to the market that artificially inflated the market price. The class period is from June 12, 2007 through March 17, 2008 (the “Class Period”). Read the rest of this entry »

Posted in Emerging Issues | 3 Comments »